Integral Health Asset Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Hold |
700,000
| – | – | 0.24% | 66 |
|
|
2025
Q1 | $1.93M | Buy |
700,000
+250,000
| +56% | +$690K | 0.21% | 69 |
|
|
2024
Q4 | $2.49M | Buy |
450,000
+150,000
| +50% | +$831K | 0.21% | 71 |
|
|
2024
Q3 | $2.5M | Buy |
+300,000
| New | +$2.5M | 0.28% | 54 |
|
|
2023
Q3 | – | Sell |
-180,000
| Closed | -$1.58M | – | 92 |
|
|
2023
Q2 | $1.58M | Buy |
180,000
+80,000
| +80% | +$700K | 0.2% | 69 |
|
|
2023
Q1 | $1.18M | Buy |
+100,000
| New | +$1.18M | 0.24% | 65 |
|